What question did this study set out to answer?

This research aims to develop a novel gene editing platform based on coacervates for hematopoietic stem cells.

December 8, 2025BloodOpen Access

A mammalian coacervate-based platform for high-efficiency gene editing in hematopoietic stem cells

View Full Paper

Ask AI

Bookmark

Authors

Coacervate technology demonstrates improved gene knockout efficiency in hematopoietic stem cells, indicating safer cell therapy options.

This research aims to develop a novel gene editing platform based on coacervates for hematopoietic stem cells.
Developed EASY, a coacervate-based gene delivery system using mammalian endogenous proteins.
Evaluated mRNA transfection efficiency and gene knockout via CRISPR in primary human CD34⁺ HSCs.
Assessed mRNA encapsulation capacity and cell viability post-transfection.
Achieved over 90% transfection efficiency for mRNA encoding green fluorescent protein.
Demonstrated successful gene knockout by modifying approximately 80% of alleles at the BCL11A locus.
Highlighted no evidence of off-target editing, indicating high specificity in gene editing.

Xiaofei Gao (2025) studied this question.

View Full Paper

Ask AI

Bookmark